SCHEMBL7908199

SCHEMBL7908199

CC(C)(NC(=O)c1cccc([N+](=O)[O-])c1N)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
CTSD P07339 1/20 0.47
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GLA P06280 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ERAP1 Q9NZ08 2/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 1/20 0.41
POLB P06746 2/20 0.40
KCNMA1 Q12791 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28446977 0.85 ALDH1A1 (0.63) CTSDALDH1A1MEN1KMT2ACYP1A2
SCHEMBL5248182 0.81 SLC6A2 (0.58) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL162559 0.77 TSHR (0.64) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL7475632 0.77 GLA (0.53) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL7475644 0.77 GLA (0.53) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL1509448 0.76 TSHR (0.62) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL28935981 0.76 TSHR (0.62) TSHRCTSDALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL27908306 0.76 TSHR (0.62) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL1509450 0.76 TSHR (0.62) TSHRCTSDALDH1A1MEN1KMT2A
SCHEMBL505223 0.76 TSHR (0.53) TSHRCTSDALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed